Group One Trading
PDSB icon

Group One Trading’s PDS Biotechnology PDSB Stock Holding History

Group One Trading’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81.9K Buy
109,147
+105,580
+2,960% +$60K ﹤0.01% 4870
2026
Q2 		$3.14K Hold
3,567
– – ﹤0.01% 6901
2026
Q1 		$2.16K Sell
3,567
-355
-9% -$267 ﹤0.01% 7028
2025
Q4 		$3.02K Buy
+3,922
New +$3.54K ﹤0.01% 7399
2024
Q3 		– Sell
-8,481
Closed -$28.3K – 7185
2024
Q2 		$24.8K Sell
8,481
-21,975
-72% -$70.3K ﹤0.01% 5066
2024
Q1 		$121K Sell
30,456
-22,686
-43% -$117K ﹤0.01% 3997
2023
Q4 		$264K Buy
53,142
+11,994
+29% +$59.6K ﹤0.01% 3610
2023
Q3 		$208K Buy
41,148
+5,740
+16% +$31.4K ﹤0.01% 3769
2023
Q2 		$178K Buy
35,408
+30,548
+629% +$200K ﹤0.01% 4065
2023
Q1 		$29.9K Sell
4,860
-4,839
-50% -$39.6K ﹤0.01% 5242
2022
Q4 		$128K Buy
9,699
+9,599
+9,599% +$67.7K ﹤0.01% 4217
2022
Q3 		$0 Sell
100
-300
-75% -$1.27K ﹤0.01% 8060
2022
Q2 		$1K Hold
400
– – ﹤0.01% 7603
2022
Q1 		$2K Buy
400
+100
+33% +$621 ﹤0.01% 7742
2021
Q4 		$2K Buy
300
+100
+50% +$1.08K ﹤0.01% 7892
2021
Q3 		$3K Buy
+200
New +$2.49K ﹤0.01% 7879
2021
Q2 		– Sell
-25
Closed -$195 – 8468
2021
Q1 		$0 Hold
25
– – ﹤0.01% 7916
2020
Q4 		$0 Hold
25
– – ﹤0.01% 6868
2020
Q3 		$0 Hold
25
– – ﹤0.01% 6436
2020
Q2 		$0 Hold
25
– – ﹤0.01% 6081
2020
Q1 		$0 Hold
25
– – ﹤0.01% 5623
2019
Q4 		$0 Hold
25
– – ﹤0.01% 5495
2019
Q3 		$0 Hold
25
– – ﹤0.01% 5439
2019
Q2 		$0 Hold
25
– – ﹤0.01% 5289
2019
Q1 		$0 Hold
25
– – ﹤0.01% 5229
2018
Q4 		$0 Hold
25
– – ﹤0.01% 5270
2018
Q3 		$0 Sell
25
-25
-50% -$449 ﹤0.01% 5513
2018
Q2 		$1K Sell
50
-200
-80% -$4.17K ﹤0.01% 4996
2018
Q1 		$6K Buy
+250
New +$67.2K ﹤0.01% 4476

Other funds holding PDSB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Inspirion Wealth Advisors
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Provenance Wealth Advisors
Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Tempus Wealth Planning
Tempus Wealth Planning Irvine, California $522M AUM 17.46% 1-Year Est. Return

Group One Trading's PDSB Position: Q3 2026 in Review

Group One Trading increased its PDS Biotechnology (PDSB) stake by 2,960% in Q3 2026, buying an estimated $60K and bringing the position to 109,147 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4870.

Group One Trading first reported a position in PDSB in Q1 2018 and has held it in 29 quarters since. The position peaked at $264K in Q4 2023. 29 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Group One Trading held 109,147 shares of PDS Biotechnology worth $81.9K as of Q3 2026.
  • Group One Trading bought 105,580 PDS Biotechnology shares in Q3 2026, an estimated $60K.
  • PDS Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4870 holding.
  • Group One Trading first reported a position in PDS Biotechnology in Q1 2018 and has held it in 29 quarters since.
  • Group One Trading's PDS Biotechnology position peaked at $264K in Q4 2023.
  • 29 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.